產(chǎn)品詳情
簡單介紹：
卵巢腫瘤蛋白1(OTUB1)重組蛋白可提供多種重組蛋白系統(tǒng)供你選擇。卵巢腫瘤蛋白1(OTUB1)重組蛋白可以從價格、周期、優(yōu)勢等方面靈活選擇，滿足你不同的科研需求。如產(chǎn)品有質(zhì)量問題可申請退換，有技術(shù)疑問可隨時給于解答，提供一對一的客服服務(wù)。
詳情介紹：
卵巢腫瘤蛋白1(OTUB1)重組蛋白
Recombinant Otubain 1 (OTUB1)
FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
| Organism species | Homo sapiens (Human) |
| Product No. | KL838Hu01 |
| Source | Prokaryotic expression |
| Host | E.coli |
| Purity | >97% |
| UOM | 50ug |
| Predicted Molecular Mass | 32.5kDa |
| Concentration | n/a |
| Applications | SDS-PAGE; WB; ELISA; IP. |
| Endotoxin Level | <1.0EU per 1μg (determined by the LAL method) |
| Residues | Met1~Lys271 (Accession # Q96FW1) with N-terminal His-Tag |
| Formulation | Supplied as lyophilized form in PBS, pH7.4, containing 5% trehalose, 0.01% sarcosyl. |
卵巢腫瘤蛋白1(OTUB1)重組蛋白SEQUENCES
The sequence of the target protein is listed below.
MGHHHHHHSGS-MAAEEPQQQK QEPLGSDSEG VNCLAYDEAI MAQQDRIQQE IAVQNPLVSE RLELSVLYKE YAEDDNIYQQ KIKDLHKKYS YIRKTRPDGN CFYRAFGFSH LEALLDDSKE LQRFKAVSAK SKEDLVSQGF TEFTIEDFHN TFMDLIEQVE KQTSVADLLA SFNDQSTSDY LVVYLRLLTS GYLQRESKFF EHFIEGGRTV KEFCQQEVEP MCKESDHIHI IALAQALSVS IQVEYMDRGE GGTTNPHIFP EGSEPKVYLL YRPGHYDILY K
MGHHHHHHSGS-MAAEEPQQQK QEPLGSDSEG VNCLAYDEAI MAQQDRIQQE IAVQNPLVSE RLELSVLYKE YAEDDNIYQQ KIKDLHKKYS YIRKTRPDGN CFYRAFGFSH LEALLDDSKE LQRFKAVSAK SKEDLVSQGF TEFTIEDFHN TFMDLIEQVE KQTSVADLLA SFNDQSTSDY LVVYLRLLTS GYLQRESKFF EHFIEGGRTV KEFCQQEVEP MCKESDHIHI IALAQALSVS IQVEYMDRGE GGTTNPHIFP EGSEPKVYLL YRPGHYDILY K
卵巢腫瘤蛋白1(OTUB1)重組蛋白USAGE
Reconstitute in sterile ddH2O.
卵巢腫瘤蛋白1(OTUB1)重組蛋白STORAGE AND STABILITY
Storage: Avoid repeated freeze/thaw cycles. Store at 2-8oC for one month. Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37oC for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition.
Stability Test: The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37oC for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition.
卵巢腫瘤蛋白1(OTUB1)重組蛋白About the MARKER (complimentary)
Effective Size Range: 10kDa to 70kDa.
Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approximation of proteins of interest quick and easy.
Ready-to-use: No need to heat, dilute or add reducing agents before use.
KL028Ra01 紅細胞生成素(EPO)重組蛋白 Recombinant Erythropoietin (EPO) Rattus norvegicus (Rat)Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approximation of proteins of interest quick and easy.
Ready-to-use: No need to heat, dilute or add reducing agents before use.
KL028Si01 紅細胞生成素(EPO)重組蛋白 Recombinant Erythropoietin (EPO) Rhesus monkey (Simian)
KL029Bo01 E選擇素(SELE)重組蛋白 Recombinant Selectin, Endothelium (SELE) Bos taurus; Bovine (Cattle)
KL029Ca01 E選擇素(SELE)重組蛋白 Recombinant Selectin, Endothelium (SELE) Canis familiaris; Canine (Dog)
KL029Cp01 E選擇素(SELE)重組蛋白 Recombinant Selectin, Endothelium (SELE) Capra hircus; Caprine (Goat)
KL029Eq01 E選擇素(SELE)重組蛋白 Recombinant Selectin, Endothelium (SELE) Equus caballus; Equine (Horse)
KL029Hu01 E選擇素(SELE)重組蛋白 Recombinant Selectin, Endothelium (SELE) Homo sapiens (Human)
KL029Mu01 E選擇素(SELE)重組蛋白 Recombinant Selectin, Endothelium (SELE) Mus musculus (Mouse)
